Wang JJ - Search Results

1

Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.

Wei ZG, Hu XL, He Y, Guan H, Wang JJ, He L, Mu XL, Liu ZR, Li RD, Peng XC. Wei ZG, et al. Among authors: wang jj. Head Neck. 2021 May;43(5):1465-1475. doi: 10.1002/hed.26608. Epub 2021 Jan 9. Head Neck. 2021. PMID: 33421240

2

Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.

He J, Cai L, Chen Y, He Y, Wang M, Tang J, Guan H, Wang J, Peng X. He J, et al. Radiother Oncol. 2018 Oct;129(1):30-37. doi: 10.1016/j.radonc.2018.02.007. Epub 2018 Mar 5. Radiother Oncol. 2018. PMID: 29519627

3

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis.

He Y, Guo T, Guan H, Wang J, Sun Y, Peng X. He Y, et al. Cancer Manag Res. 2018 Jun 6;10:1419-1428. doi: 10.2147/CMAR.S160469. eCollection 2018. Cancer Manag Res. 2018. PMID: 29922086 Free PMC article.

4

Which induction chemotherapy regimen followed by cisplatin-based concurrent chemoradiotherapy is the best choice among PF, TP and TPF for locoregionally advanced nasopharyngeal carcinoma?

He Y, Guo T, Wang J, Sun Y, Guan H, Wu S, Peng X. He Y, et al. Ann Transl Med. 2019 Mar;7(5):104. doi: 10.21037/atm.2019.02.15. Ann Transl Med. 2019. PMID: 31019954 Free PMC article.

5

Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma.

He J, He J, Min L, He Y, Guan H, Wang J, Peng X. He J, et al. Int J Cancer. 2020 Feb 15;146(4):1052-1063. doi: 10.1002/ijc.32543. Epub 2019 Jul 16. Int J Cancer. 2020. PMID: 31259424

6

Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.

Wang J, Wang Y, He Y, Guan H, He L, Mu X, Peng X. Wang J, et al. Trials. 2019 Nov 21;20(1):641. doi: 10.1186/s13063-019-3741-5. Trials. 2019. PMID: 31752981 Free PMC article.

7

Assessment of induction chemotherapy regimen TPF vs GP followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A retrospective cohort study of 160 patients.

Guan H, He Y, Wei Z, Wang J, He L, Mu X, Peng X. Guan H, et al. Clin Otolaryngol. 2020 Mar;45(2):274-279. doi: 10.1111/coa.13489. Epub 2019 Dec 13. Clin Otolaryngol. 2020. PMID: 31788988 No abstract available.

8

Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.

He Y, Zhao Z, Wang Y, Chai J, He J, Wang J, He L, Guan H, Wei Z, Liu Z, Mu X, Peng X. He Y, et al. Head Neck. 2020 Aug;42(8):2067-2076. doi: 10.1002/hed.26141. Epub 2020 Mar 23. Head Neck. 2020. PMID: 32202686

9

Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.

Wang J, Yan L, Ai P, He Y, Guan H, Wei Z, He L, Mu X, Liu Y, Peng X. Wang J, et al. Neurosurg Rev. 2021 Jun;44(3):1447-1455. doi: 10.1007/s10143-020-01326-y. Epub 2020 Jun 11. Neurosurg Rev. 2021. PMID: 32529528

10

Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience.

He L, Xiao J, Wei Z, He Y, Wang J, Guan H, Mu X, Peng X. He L, et al. Oral Oncol. 2020 Aug 27;109:104978. doi: 10.1016/j.oraloncology.2020.104978. Online ahead of print. Oral Oncol. 2020. PMID: 32861986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,278 results

Search Page

Filters